Cayci Tuncer, Akgul Emin Ozgur, Kurt Yasemin Gulcan, Ceyhan Temel S, Aydin Ibrahim, Onguru Onder, Yaman Halil, Cakir Erdinc, Yasar Mehmet, Bilgi Cumhur, Erbil Kemal M
Department of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey.
J Obstet Gynaecol Res. 2011 Aug;37(8):1041-7. doi: 10.1111/j.1447-0756.2010.01482.x. Epub 2011 Apr 12.
To investigate the levels of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) in all the rat endometriosis models.
MATERIAL & METHODS: Forty-one rats with endometriotic implants were divided into four groups (1 to 4) and administered infliximab, etanercept, letrozole and control, respectively. There were 11 rats in group 5 (normal). The size of implants, plasma ADMA and nitrate/nitrite (NO(x) ) levels and histological score were assessed.
In groups 1, 2 and 3, plasma ADMA levels were higher than groups 4 and 5, 296.8 ± 66.2, 285.9 ± 35.7, 200.3 ± 41.0, 125.3 ± 16.7, 111.3 ± 6.5 µmol/L, respectively, while NO(x) levels were lower than groups of control and normal 19.6 ± 3.8, 19.8 ± 4.4, 39.3 ± 6.1, 80.5 ± 5.3, and 91.1 ± 5.0 µmol/L, respectively.
Infliximab, etanercept and letrozole have regressed endometriotic implants, decreased plasma NO(x) levels, and increased plasma ADMA levels.
研究所有大鼠子宫内膜异位症模型中一氧化氮(NO)和不对称二甲基精氨酸(ADMA)的水平。
将41只患有子宫内膜异位植入物的大鼠分为四组(1至4组),分别给予英夫利昔单抗、依那西普、来曲唑和作为对照。第5组有11只大鼠(正常)。评估植入物大小、血浆ADMA和硝酸盐/亚硝酸盐(NO(x))水平以及组织学评分。
在第1、2和3组中,血浆ADMA水平高于第4组和第5组,分别为296.8±66.2、285.9±35.7、200.3±41.0、125.3±16.7、111.3±6.5μmol/L,而NO(x)水平低于对照组和正常组,分别为19.6±3.8、19.8±4.4、39.3±6.1、80.5±5.3和91.1±5.0μmol/L。
英夫利昔单抗、依那西普和来曲唑使子宫内膜异位植入物消退,降低血浆NO(x)水平,并升高血浆ADMA水平。